Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.

Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A, Heldin CH.

Biochem Biophys Res Commun. 1992 May 15;184(3):1311-6.

PMID:
1590793
2.

Platelet-derived endothelial cell growth factor.

Miyazono K, Usuki K, Heldin CH.

Prog Growth Factor Res. 1991;3(3):207-17. Review.

PMID:
1811791
3.

Platelet-derived endothelial cell growth factor: structure and function.

Miyazono K, Takaku F.

Jpn Circ J. 1991 Oct;55(10):1022-6. Review.

PMID:
1744978
4.

Platelet-derived endothelial cell growth factor.

Heldin CH, Usuki K, Miyazono K.

J Cell Biochem. 1991 Nov;47(3):208-10. Review.

PMID:
1724243
5.

Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.

Pérez-Pérez MJ, Priego EM, Hernández AI, Camarasa MJ, Balzarini J, Liekens S.

Mini Rev Med Chem. 2005 Dec;5(12):1113-23. Review.

PMID:
16375757
6.

Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.

Liekens S, Bronckaers A, Pérez-Pérez MJ, Balzarini J.

Biochem Pharmacol. 2007 Dec 3;74(11):1555-67. Epub 2007 May 16. Review.

PMID:
17572389
7.
8.

[Demonstration of thymidine phosphorylase activity in human healthy, adenomatous and cancerous prostate].

Touffet S, Gayet G, Sampérez S, Jouan P.

Bull Cancer. 1992;79(2):151-9. Review. French.

PMID:
1382732
Items per page

Supplemental Content

Write to the Help Desk